Dr. Reddy’s Laboratories Ltd., incorporated in the year 1984, is a Large Cap company (having a market cap of Rs 81375.35 Crore) operating in Pharmaceuticals sector.
Financials
For the quarter ended 31-12-2020, the company reported a Consolidated Total Income of Rs 5012.40 Crore, up 1.01 % from last quarter Total Income of Rs 4962.10 Crore and up 12.27 % from last year same quarter Total Income of Rs 4464.40 Crore. Company reported net profit after tax of Rs 12.80 Crore in latest quarter.
Investment Rationale
The recent swift throwback from higher levels could mean that stock is due for mean reversion. On the flipside, the stock is likely to revisit the levels of Rs 4,700.
Promoter/FII Holdings
Promoters held 26.7 per cent stake in the company as of Dec 30, 2020, while FIIs held 29.4 per cent, DIIs 14.7 per cent and public and others 29.2 per cent.
